Stock ORAMED PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Oramed Pharmaceuticals, Inc. OTC Bulletin Board

Equities

US68403P1049

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Oramed Pharmaceuticals, Inc.
15/05 Compugen Names David Silberman CFO MT
13/05 Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Compugen Names David Silberman CFO
MT
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024
CI
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024
CI
Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K
PU
Oramed: Q1 Earnings Snapshot
AQ
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction
PU
Oramed Pharmaceuticals : 13D-Nadav Kidron
PU
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction
PU
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024
CI
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors
CI
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals : Other Report or Announcement
PU
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024
CI
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.
PU
Oramed: Q3 Earnings Snapshot
AQ
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORMP Stock
  4. Stock
  5. News Oramed Pharmaceuticals, Inc.